Actinova Limited

Affitech As

Lars Bj&ouml;rck

Arne Ols&eacute;n

Heiko Herwald

Ulf Sj&ouml;bring

Werner M&uuml;ller-Esterl

Abdelhakim Ben Nasr

Ulf Sj&ouml;rbring

Eva Mattsson

The invention relates to sequences of protein L which bind to light chains of immunoglobulins. The invention also relates to hybrid proteins thereof which are able to bind to both light and heavy chains of immunoglobulin G, in particular protein LG. The invention also relates to DNA-sequences which code for the proteins, vectors which include such DNA-sequences, host cells which have been transformed with the vectors, methods for producing the proteins, reagent appliances for separation and identification of immunoglobulins, compositions and pharmaceutical compositions and pharmaceutical compositions which contain the proteins.

Protein L and hybrid proteins thereof

Treatment of bacterial infections

Kinin antagonists, especially bradykinin antagonists, can be used for treating bacterial infections, in particular infections caused by bacteria belonging to the genera Streptococcus, Escherichia, Salmonella, Staphylococcus, Klebsiella, Moracella, Haemophilus and Yersinia.

Use of kinin antagonists for preparing a pharmaceutical composition for treating bacterial infections

Growing community of inventors

Lund, Sweden

Lars Björck

Growing community of inventors

Lund, Sweden

Lars Bj&ouml;rck

Lars Björck